Results 151 to 160 of about 64,482 (277)
Detection of autoantibodies against thyroglobulin, thyroid microsomes, and other soluble antigens with a rational and economical immunoblotting microtechnique [PDF]
, 1985 Berndt, H. +5 more
core +1 more source
The Journal of Physiology, EarlyView.Abstract figure legend A study described in this paper describes a new tool for hiPSC‐CM electromechanical behaviour simulations using mathematical modelling. The model enables in silico assays making drug testing quick, comprehensive and accurate. New hiPSC‐CM models can be used as a platform to integrate in vitro and in silico findings.
Milda Folkmanaite +9 more
wiley +1 more source
The Journal of Physiology, EarlyView.Abstract figure legend Suboptimal maternal nutrition alters placental and developing blood–brain barrier (BBB) protective function and is associated with increased fetal brain vulnerability. In the placenta, nutritional adversity may reduce the exchange surface area and promote meta‐inflammation, compromising barrier efficiency in a model‐ and context ...
Kristin L. Connor +4 more
wiley +1 more source
Let's retire phenytoin! Levetiracetam as the first choice in the treatment of convulsive status epilepticus. [PDF]
Arq NeuropsiquiatrCaboclo LO, Frota CLL.
europepmc +1 more source
Excretion of organic acids associated with biotin deficiency in chronic anticonvulsant therapy [PDF]
, 1984 Berlit, Peter +3 more
core
Clozapine for treatment‐resistant schizophrenia with epilepsy: A case report
Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.Clozapine (CLOZ) is often avoided in treatment‐resistant schizophrenia with comorbid epilepsy due to seizure risks. We report a successful case managed through a cautious CLOZ titration guided by multimodal monitoring, including clinical scales and blood tests such as C‐reactive protein (CRP), CLOZ levels, and anti‐seizure medication (ASM) levels ...
Toru Horinouchi +5 more
wiley +1 more source
Self-healing PVA/PVP micelle-hydrogel composite system for potential phenytoin repositioning in wound healing. [PDF]
J Biol EngMachado-Torres K +3 more
europepmc +1 more source
Australasian Journal on Ageing, Volume 45, Issue 2, June 2026.ABSTRACT Objective Apixaban is widely recommended as first line therapy for atrial fibrillation (AF) and venous thromboembolism (VTE). Despite the widespread availability of dosing guidelines, anecdotal evidence suggests clinicians do not routinely follow these recommendations. Inappropriate dose reduction is associated with suboptimal patient outcomes.
Katherine J. Creeper +5 more
wiley +1 more source
Between the retirement of phenytoin and the crowning of levetiracetam: balancing innovation, safety, accessibility and well-established practices. [PDF]
Arq NeuropsiquiatrPinto LF.
europepmc +1 more source
Contact Dermatitis, Volume 94, Issue 6, Page 677-688, June 2026.This study provides reassuring evidence in favour of early skin testing in patients with SCARs, argues against the necessity of a 6‐month delay, and underscores the pivotal role of oral provocation tests in the safe reintroduction of essential therapies. ABSTRACT Background Identifying and discontinuing the offending drug(s) in severe cutaneous adverse
Zohra Chadli +8 more
wiley +1 more source